Laboratory predictors of clinical outcomes in patients with atrial fibrillation
Atrial fibrillation (AF) is the most common cardiac arrhythmia in clinical practice that affects intracardiac hemodynamics and is accompanied by increased mortality due to the risk of stroke and systemic thromboembolism. In recent years, numerous studies, evaluating the use of biomarkers in AF patie...
Saved in:
Main Authors: | A. A. Sokolova, I. V. Goncharova, A. A. Vedernikov, N. S. Morozova, D. A. Napalkov |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2021-05-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/2444 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Maximum time between cardiac cycles in atrial fibrillation for assessing the risk of arterial thromboembolism
by: O. A. Germanova, et al.
Published: (2022-08-01) -
Optimal choice of prophylactic anticoagulant therapy for nonvalvular atrial fibrillation in the context of COVID-19 pandemic
by: A. S. Polyakov, et al.
Published: (2021-09-01) -
Factors determining adherence to anticoagulant therapy in patients with atrial fibrillation
by: D. V. Pevzner, et al.
Published: (2023-06-01) -
Predictive markers of atrial fibrillation in patients after acute ST-elevated myocardial infarction (the results of observational program “FAKEL”)
by: I. A. Zolotovskaya, et al.
Published: (2018-10-01) -
COMPARISON OF SCHEMES OF PERIOPERATIONAL ANTICOAGULATION IN ATRIAL FIBRILLATION PATIENTS DEMANDING FOR SURGERY
by: L. N. Uddin, et al.
Published: (2018-06-01)